Senate Committee Reviews Patent Eligibility Restoration Act to Broaden What Inventions Can Be Patented
Stalled
No legislative action in over 90 days.
How this policy affects specific groups of people
Read twice and referred to the Committee on the Judiciary.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.

The bill aims to restore patent eligibility for cutting-edge technologies like diagnostics and AI by overturning Supreme Court decisions that created uncertainty. It specifies that isolated human genes are not eligible, but purified or modified ones are.
A Senate hearing examined the bill's impact on Section 101, featuring testimony from former USPTO directors. The 2025 version narrows the human gene provision compared to earlier drafts, requiring purification or modification for eligibility.
Document Type
Congressional Bill
Official Title
Patent Eligibility Restoration Act of 2025
Analysis generated by AI. Always verify with official sources.